Latest News

General Abstract Submission: The submission deadline for abstracts on HIV and hepatitis viruses and their related conditions is September 20, 2022. Submission is set to open in late August. The submission deadline for late-breaking abstracts on HIV and hepatitis viruses plus all COVID science and monkeypox science is January 5, 2023. The 30th Conference on Retroviruses […]

Arthur Y. Kim, MD (Harvard Medical School)  presented a webinar titled Simplifying Treatment of Hepatitis C and Overcoming Barriers to Cure on August 2, 2022. To access the on-demand activity, visit https://www.iasusa.org/courses/on-demand-webinar-2022-kim/. Continuing Education Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. […]

The TAM 30.3 issue includes new data in the field of HIV and related infections in regards to neurologic and metabolic complications, and advances in treatment of HIV, COVID-19, and viral hepatitis. This issue offers up to 4.5 CME credits. Continuing Education Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing [...]

Betty J. Dong, PharmD (University of California San Francisco) presented a webinar titled Key Antiretroviral Drug-Drug Interactions With Mycobacterium tuberculosis Infection in Persons With HIV: A Case-Based Presentation on July 26, 2022. To access the on-demand activity, visit https://www.iasusa.org/courses/on-demand-webinar-2022-dong/. Continuing Education Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical […]

Thank you for completing the online survey that the University of California San Diego conducted to assess demographics, transgender care training, comfort, prescribing practices, and knowledge. This survey was sent to 2570 members of the International Antiviral Society-USA (IAS-USA) who attended an IAS-USA conference or completed an IAS-USA Webinar for CME credit in the last […]

This on-demand activity is from the virtual program presented on July 20, 2022. This on-demand course includes an overview of the clinical relationship between HIV and COVID-19, 2 case-based panel discussions on difficult cases in prevention, outpatient care, and inpatient care for COVID-19, including what drugs to use and when, and a discussion on post-COVID-19 [...]

An early e-publication article, CROI 2022: Advances in Antiviral Therapy for HIV, COVID-19, and Viral Hepatitis, is now available in Topics in Antiviral Medicine™. This article is written by Shauna H. Gunaratne, MD, MPH; Hong-Van Tieu, MD, MS; Timothy J. Wilkin, MD, MPH; Barbara S. Taylor, MD, MS. Read Article

David L. Wyles, MD (Denver Health Medical Center) presented a webinar titled Unique Issues in People With HIV and Hepatitis B/D Coinfections on July 19, 2022. To access the on-demand activity, visit https://www.iasusa.org/events/webinar-2022-wyles/. Continuing Education Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing […]

Our July 7th Dialogue on a Detailed Discussion on the Latest Issues in COVID-19 Rebound, Omicron Subvariants BA.4 and BA.5, Current and Next Generation COVID-19 Vaccines, Pediatric Vaccine Rollout, Monkeypox, and More, with Drs Yvonne Maldonado (Stanford University), Peter Chin-Hong (University of California San Francisco), and Michael S. Saag (University of Alabama at Birmingham) and […]

Our June 28th webinar on Implementation of Long-Acting PrEP: Case-Based Panel Discussion With Clinicians, presented by Colleen Kelley, MD, MPH (Emory University), Kim Scarsi, PharmD (University of Nebraska Medical Center), and Hyman Scott, MD, MPH (University of California San Francisco) and moderated by Jose Castillo-Mancilla, MD (University of Colorado Anschutz) is available on-demand at https://www.iasusa.org/courses/on-demand-webinar-2022-prep-panel/. Continuing [...]